Dr. Roach: With severe dementia, medications are of limited benefit
His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...
Dementia hits clever people harder, study finds
The neurodegenerative disease is the leading cause of death in the UK and is caused by certain proteins clumping together in ...
Integrating palliative and dementia care can cut emergency visits and hospitalizations in half
IN-PEACE, which provides palliative care integrated with state-of-the-art dementia care to patients with dementia and their ...
New study finds people with this particular strength are more likely to get dementia
While education is known to bolster the brain’s resilience – referred to as "cognitive reserve" – it appears that individuals ...
EurekAlert!5d
JAMA study integrates palliative and dementia care for patients and caregivers
IN-PEACE, which provides palliative care integrated with state-of-the-art dementia care to patients with dementia and their caregivers, cut in half the number of emergency department visits and ...
Opinion
Sun Journal3dOpinion
With severe dementia, medications are of limited benefit
My 89-year-old husband was diagnosed with Alzheimer’s disease. He does not take any medication. He is in excellent health except for the Alzheimer’s. His blood pressure is 123/69 mm Hg, and his pulse ...
StudyFinds on MSN3d
Bacteria in your mouth could fuel dementia
Discover the surprising link between mouth bacteria and cognitive function. Learn how oral health may play a role in brain ...
Your Good Health: Medications have limited benefit for severe dementia
At Stage 5 of the Global Deterioration Scale, a person can’t safely live without assistance. Unfortunately, the treatments at this stage are of limited benefit.
Live Science on MSN11d
Faster brain aging tied to X chromosome inherited from Mom
Female mammals typically carry two X chromosomes — one from each parent — and a new study suggests that the maternal X is ...
CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference
Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from ...
Daily Express8d
New study finds people with this particular strength are more likely to get dementia
While education is known to bolster the brain’s resilience ... reserve has been used up and dementia is diagnosed, these people are already at a more advanced stage of the underlying disease ...